Researchers Developed New Serum Hemoglobin Assay
The novel test offers improved accuracy for measuring free hemoglobin levels compared to conventional point-of-care methods.
Updated on Oct. 13, 2026 in Heart Disease
Live Poll
Do you trust that new medical testing methods lead to better surgical outcomes for patients?
Scientists have created a new latex agglutination immunoturbidimetric assay designed to measure serum free hemoglobin. The method provides results that align closely with high-performance liquid chromatography in clinical blood samples.
Why it matters
Excess free hemoglobin resulting from severe hemolysis can lead to significant organ damage in patients. Improved measurement accuracy is essential for monitoring and managing this complication in clinical settings.
The study utilized a cohort of 20 adult patients undergoing cardiovascular surgery and analyzed 119 stored blood samples. Researchers found the new assay displayed minimal random error, unlike conventional methods which showed fixed and proportional biases.
The details
The research team used Bland-Altman analysis to confirm agreement between the new assay and high-performance liquid chromatography, the established reference method. Perioperative changes were measured by tracking free hemoglobin levels both before and after the administration of Haptoglobin.
Timeline
The research findings were released on October 13, 2026.
The Big Picture
This development represents a departure from the historical use of point-of-care hemolysis monitoring, which often suffers from significant fixed and proportional biases. By aligning with high-performance liquid chromatography standards, this tool helps bridge the gap between bedside convenience and lab-grade precision.
This advancement aims to provide clinicians with more reliable data to assess patients at risk of organ damage from severe hemolysis. Over time, higher precision in blood monitoring may lead to more effective clinical decisions regarding Haptoglobin administration and post-surgical recovery.
The takeaway
Reliable testing is the cornerstone of managing patients recovering from complex cardiovascular procedures. Ensuring precise measurements of blood components helps medical teams intervene faster when dangerous hemolysis occurs.
Further reading
For more information on the diagnostic tools used in cardiac care, visit Heart Disease.
Source note: This article includes information reported by Nature.
Live Poll
Do you trust that new medical testing methods lead to better surgical outcomes for patients?
